Safety of the first dose of fingolimod for multiple sclerosis: results of an open-label clinical...

Background: In patients with relapsing-remitting MS (RRMS) fingolimod prevents disease rel http://t.co/6nGCeyzxRg

via VAT ENGPlus Combo | VATPlus | MotionTrak http://t.co/6nGCeyzxRg